Evidence map›Paper›PMID 33898784›Full record

ArticlePhysics and imaging in radiation oncology2021

Impact of interfractional target motion in locally advanced cervical cancer patients treated with spot scanning proton therapy using an internal target volume strategy.

Stéphane Niyoteka, Thomas Berger, Lars Ulrik Fokdal, Jørgen Breede Baltzer Petersen, Andras Zolnay, Mischa Hoogeman, Kari Tanderup, Håkan Ulf Nystrom

Open access · goldAbstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Stéphane NiyotekaDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Thomas BergerDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Lars Ulrik FokdalDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Jørgen Breede Baltzer PetersenDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Andras ZolnayErasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Radiotherapy, The Netherlands.
Mischa HoogemanErasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Radiotherapy, The Netherlands.
Kari TanderupDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Håkan Ulf NystromDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Aarhus University Hospital · DKErasmus MC Cancer Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe more localized dose deposition of proton therapy (PT) compared to photon therapy might allow a reduction in treatment-related side effects but induces additional challenges to address. The aim of this study was to evaluate the impact of interfractional motion on the target and organs at risk (OARs) in cervical cancer patients treated with spot scanning PT using an internal target volume (ITV) strategy. METHODS AND MATERIALS: For ten locally advanced cervical cancer patients, empty and full bladder planning computed tomography (pCT) as well as 25 daily cone beam CTs (CBCTs) were available. The Clinical Target Volume (CTV), the High Risk CTV (CTV

resultsThe ITV strategy ensured a total accumulated dose >42.75 Gy(RBE) to the CTV

conclusionThe ITV concept ensured adequate dose to the CTV

Indexed as

Adaptive radiotherapyCervix cancerInter-fraction motionProton therapy

Identifiers

PMID33898784
PMCPMC8058016
OpenAlexW3128967896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.